Our trial suggests that DHA supplementation at 500 mg/day in the 3rd trimester of pregnancy in GDM women does not affect cord blood metabolic health biomarkers including leptin, adiponectin and IGF-1. This evidence concerns the gene LEP and gestational diabetes.